ESMCOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends June 30
ESCALON MEDICAL CORP
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Oct 13, 2026
$0.18+0.01 (+7.65%)
Close on Oct 19, 2026
Market cap
$2.72M
P/E (TTM)
0.7
Dividend yield
–
Escalon Medical statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Electromedical & Electrotherapeutic Apparatus companies for comparison
Valuation
Measure
Escalon Medical
Industry median
Market Cap
$1.36M
$229.23M
Enterprise Value
-$1.71M
$194.73M
PE Ratio
0.68
33.41
PS Ratio
0.11
3.14
PB Ratio
0.23
3.19
P/TBV Ratio
0.23
4.69
Enterprise value
Measure
Escalon Medical
Industry median
EV / Sales
-0.13
2.93
EV / EBITDA
-25.19
19.97
EV / EBIT
-37.77
25.47
Income (trailing twelve months)
Measure
Escalon Medical
Industry median
Revenue
$12.74M
$102.39M
Gross Profit
$5.57M
$60.36M
Operating Income
$45.24K
-$4.31M
Net Income
$4.01M
-$6.57M
EBITDA
$67.82K
-$1.98M
EPS (Diluted)
$0.27
-$0.07
Margins
Measure
Escalon Medical
Industry median
Gross Margin
43.7%
55.1%
Operating Margin
0.36%
-6.04%
Profit Margin
31.5%
-10.5%
EBITDA Margin
0.53%
-2.67%
FCF Margin
-3.20%
-0.30%
Returns
Measure
Escalon Medical
Industry median
Return on Equity (ROE)
102.3%
-19.2%
Return on Assets (ROA)
56.8%
-13.3%
Return on Invested Capital (ROIC)
1.69%
-4.11%
Return on Capital Employed (ROCE)
0.67%
-9.07%
Growth
Measure
Escalon Medical
Industry median
Revenue Growth (YoY)
5.73%
8.85%
Net Income Growth (YoY)
3702.5%
10.6%
FCF Growth (YoY)
-208.0%
10.6%
Revenue Growth (3Y CAGR)
1.50%
7.08%
Revenue Growth (5Y CAGR)
3.99%
11.8%
EPS Growth (3Y CAGR)
108.0%
3.06%
Balance sheet
Measure
Escalon Medical
Industry median
Cash & Short-Term Investments
$3.07M
$37.33M
Net Cash (Debt)
$3.07M
$3.92M
Net Cash Per Share
$0.41
$0.28
Equity (Book Value)
$5.93M
$57.36M
Book Value Per Share
$0.80
$2.81
Tangible Book Value
$5.92M
$10.71M
Working Capital
$4.62M
$54.64M
Financial position
Measure
Escalon Medical
Industry median
Current Ratio
2.94
2.50
Quick Ratio
2.08
1.54
Interest Coverage
6.06
-1.81
Cash flow (trailing twelve months)
Measure
Escalon Medical
Industry median
Operating Cash Flow
-$402.60K
-$653.46K
Capital Expenditures
-$4.42K
-$3.69M
Free Cash Flow
-$407.03K
-$835.02K
FCF Per Share
-$0.05
-$0.02
Efficiency
Measure
Escalon Medical
Industry median
Asset Turnover
1.80
0.59
Inventory Turnover
3.70
2.21
Revenue Per Employee
$318.40K
$322.75K
Profits Per Employee
$100.32K
-$52.11K
Employee Count
40
197
Dividends and yields
Measure
Escalon Medical
Industry median
Earnings Yield
295.7%
-6.92%
FCF Yield
-30.0%
-0.62%
Shares
Measure
Escalon Medical
Industry median
Shares Outstanding
7,415,330
44,856,700
Shares Change (YoY)
2.41%
3.35%
Shares Change (QoQ)
0.00%
0.27%
Float
7,415,330
36,934,400
Shares Held by Insiders
0.00%
10.6%
Taxes
Measure
Escalon Medical
Industry median
Income Tax
-$1.14M
$1.52M
Scores
Measure
Escalon Medical
Industry median
Graham Number
$2.20
$34.37
Graham Upside
1104.2%
-58.3%
Altman Z-Score
-7.61
1.95
Piotroski F-Score
5
5
Beneish M-Score
1.15
-2.64
Calculated by StockData from Escalon Medical's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.